Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease

Background Studies report that up to 80% of individuals with chronic obstructive pulmonary disease (COPD) may struggle with symptoms of depression. However, this major comorbidity in COPD is rarely managed effectively. A number of recent studies indicate that left untreated, COPD‐related depression...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2018-12, Vol.2018 (12), p.CD012346
Hauptverfasser:	Pollok, Justyna, van Agteren, Joep EM, Carson‐Chahhoud, Kristin V
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult All pharmacological Antidepressive Agents, Tricyclic Antidepressive Agents, Tricyclic - adverse effects Antidepressive Agents, Tricyclic - therapeutic use Chronic obstructive pulmonary disease (exacerbations) Chronic obstructive pulmonary disease (stable) Condition Depression Depression - drug therapy Depression - etiology Depressive disorder Depressive disorder, major Depressive disorders & major depression Dizziness Dizziness - chemically induced Dyspnea Dyspnea - drug therapy Exercise Tolerance Exercise Tolerance - drug effects Forced Expiratory Volume Forced Expiratory Volume - drug effects Humans Intervention Lungs & airways Medicine General & Introductory Medical Sciences Mental health Mood disorders Nausea Nausea - chemically induced Nortriptyline Nortriptyline - adverse effects Nortriptyline - therapeutic use Older people Other medications Paroxetine Paroxetine - adverse effects Paroxetine - therapeutic use Placebos Placebos - therapeutic use Population Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Chronic Obstructive - psychology Quality of Life Randomized Controlled Trials as Topic Selective Serotonin Reuptake Inhibitors - adverse effects Selective Serotonin Reuptake Inhibitors - therapeutic use Serotonin Uptake Inhibitors Sertraline Sertraline - adverse effects Sertraline - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!